Teenagers not included in enough cancer trials Cancer Research UK - News & Resources, UK - British researchers analysed enrolment in phase III clinical trials from April 2005 to March 2007 involving teenagers and young adults (TYA) and children. ...
Genta - Waiting For Genasense To Make Sense Trading Markets (press release), CA - The FDA lifted the clinical hold on Tesetaxel on June 23, 2008 and Genta has completed regulatory filings needed to resume clinical trials. ...OTC:GNTA
New arena for testing of drugs: Real world The Punch, Nigeria - Nov 29, 2008 They are good for generating hypotheses or perhaps when clinical trials are impractical. But as evidence? They are about as accurate as tossing a coin. ...
Teens 'miss out' on cancer trials BBC News, UK - Nov 27, 2008 Teenagers with cancer are not being included in UK clinical trials which could improve their chances of survival, according to researchers. Trials from 2005...
Llew Keltner ? Battling solid tumours with light Pharmaceutical Technology Europe, UK - Q3: The potential of Litx is already being explored in several clinical trials. What have the results been like thus far? Preclinical, Phase I, Phase II, ...
Intensive Lipid Intervention in the Post-ENHANCE Era RedOrbit, TX - Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. Curr Med Res Opin. ...
Peripheral Arterial Disease: Diagnosis and Management RedOrbit, TX - Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel UJ guidelines [published correction appears in ...
… for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update Endorsed by the … - SC Smith, J Allen, SN Blair, RO Bonow, LM Brass, … - Journal of the American College of Cardiology, 2006 - Am Coll Cardio Found ... Physical Activity, and Metabolism Clinical implications of ... PEACE Trial Investigators
Angiotensin-converting-enzyme inhibition ... AHA 2002 guideline update for the ...
Here are the latest clinical trials, courtesy of CenterWatch:
Neuroendocrine Carcinoma
The Folfox plus bevacizumab combination is being studied in patients with neuroendocrine tumors because Folfox appears to inhibit the growth of a variety of different tumor types but has not yet been tested in this disease. Participants must be 18 years or older, male or female with pathologic (histological or cytological) confirmation of neuroendocrine carcinoma. Research site located in San Francisco, Calif.
The primary purpose of this study is to determine whether treatment with an experimental gene therapy (Biobypass) will reduce angina in study participants by stimulating the growth of new blood vessels. Qualified participants must be between 18 and 80, have provided written informed consent prior to any study dictated procedure, and have moderate-to-severe angina (CCS Angina Class II-IV) despite optimal medical therapy. Research sites located in North Denmark, Denmark, Israel and United Kingdom.
Researchers are conducting a study of an investigational drug for the treatment of lower back pain, i.e. sensations of burning or pins and needles that shoot down the leg and/or foot (lumbosacral radiculopathy). Qualified participants must be at least 18, have experienced back pain that radiates to the leg and/or foot as a result of disc herniation or spinal stenosis (narrowing of the inside of the spinal canal or of the spinal nerve pathways). Research site located in Portland, Ore.
